Skip to main content
  • Contact Us
  • Investors & Media
    • Stock Information
    • Press Releases
    • Events
    • SEC Filings
    • Annual Report and Proxy
    • Analyst Coverage
    • Investor FAQ
    • Corporate Governance
    • Email Alerts
    • IR/Media Contacts
Cytokinetics logo
  • Mission
    • Science Behind Muscle
    • Heart Failure
    • Hypertrophic Cardiomyopathy
    • Neuromuscular Disease
  • Science
    • Pipeline
    • Publications
    • Clinical Trials
    • Access Policy
    • Investigator-Initiated Research
  • Our Medicine
  • Company
    • Our Story
    • Vision
    • Values
    • Leadership Teams
  • Responsibility
    • Patient Advocacy
    • Access To Our Medicines
    • Community Engagement
    • Grants and Giving Programs
    • Resilience in the Fight Against ALS
  • Careers
    • Culture
    • Open Opportunities
    • Diversity, Equity, Inclusion & Respect
    • Internship Program
    • Post-Doc Program
    • Fraud Warning
cytokinetics logo
  • Home
  • Mission
  • Science
  • Our Medicine
  • Company
  • Responsibility
  • Careers
  • Updated Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Patent Notices

CYTOKINETICS® and the C logo are registered trademarks of Cytokinetics in the U.S. and certain other countries.

Cytokinetics scientists and collaborators are committed to high scientific and ethical publications standards and are dedicated to providing our science to the medical and scientific community through peer-reviewed journals and medical forums. Our scientific publications (e.g., manuscripts, posters and/or oral presentations that contain data from Cytokinetics-sponsored studies, have Cytokinetics authors, or for which Cytokinetics provides writing and/or editorial assistance) are generally intended for health care professionals.

If you have specific questions or require additional information, please contact Cytokinetics Medical Information at [email protected].

Note: All content provided as is and per applicable permissions; some links provided below redirect to third-party websites that may require a subscription to access publications.

I understand

Cytokinetics scientists and collaborators are committed to high scientific and ethical research standards and are dedicated to better understanding and advancing the science of muscle biology and diseases of muscle dysfunction. Our Investigator-Initiated Research program is intended for scientists and health care professionals.

If you have specific questions or require additional information, please contact the Cytokinetics Investigator-Initiated Research team at [email protected] (clinical submissions) or [email protected] (non-clinical or pre-clinical submissions).

Note: All content provided as is and per applicable permissions; some links provided below redirect to third-party websites that may require a subscription to access publications.

I understand

We’re proud to announce that the U.S. Food and Drug Administration has approved MYQORZO™ (aficamten)!

Read our press release

Please see Full Prescribing Information, including BOXED WARNING here.